http://archive.fast-edgar.com/20240517/AUZ2362CSC227ZRK22282ZZ27AA6W228Z262
Filed on: May 17, 2024
http://archive.fast-edgar.com/20240517/A2VZU22CZ222O2Z2222R22ZJNWL6ZW228T62
Filed on: May 17, 2024
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
May, 2024
Commission File Number 1-15182
DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
+91-40-49002900
(Address of principal executive... (continue reading...)
Pricing supplement
To prospectus dated April 13, 2023,
prospectus supplement dated April 13, 2023 and
product supplement no. 1-I dated April 13, 2023
Registration Statement No. 333-270004
Dated May 15, 2024
Rule 424(b)(2)
$6,000,000
Callable Fixed Rate Notes due May 17, 2034
General
·The notes are unsecured and unsubordinated obligations of JPMorgan Chase & Co. Any payment on the... (continue reading...)More SEC Filings
View Older Stories-
Form 6-K Cadeler A/S For: May 17
-
Form 4 INTEVAC INC For: May 16 Filed by: Klein Michele
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 TECOGEN INC. For: May 16 Filed by: HATSOPOULOS JOHN
-
Form 4 Spectral AI, Inc. For: May 15 Filed by: SPANGENBERG ERICH
-
Form 8-K Infinera Corp For: May 17
-
Form 6-K New Gold Inc. /FI For: May 17
-
Form 6-K Grupo Supervielle S.A. For: May 16
-
Form 4 Accenture plc For: May 15 Filed by: Sweet Julie Spellman
-
Form ARS GENESCO INC For: Feb 03
-
Form 4 Accenture plc For: May 15 Filed by: Brudermueller Martin
-
Form 4 MATERION Corp For: May 15 Filed by: LIGGETT EMILY M
-
Form 4 INTEVAC INC For: May 16 Filed by: HAYES DOROTHY D
-
Form 4 Accenture plc For: May 15 Filed by: SARIN ARUN
-
Form 4 Accenture plc For: May 15 Filed by: Burgum Melissa A
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 10-K Infinera Corp For: Dec 30
-
Form 4 Accenture plc For: May 15 Filed by: Walsh John F
-
Form 4 Accenture plc For: May 15 Filed by: McKinstry Nancy
-
Form 4 Accenture plc For: May 15 Filed by: Jope Alan C.
-
Form 4 Accenture plc For: May 15 Filed by: Sharma Manish
-
Form 4 Accenture plc For: May 15 Filed by: Shook Ellyn
-
Form 4 Accenture plc For: May 15 Filed by: Price Paula A
-
Form 4 Accenture plc For: May 15 Filed by: Ollagnier Jean-Marc
-
Form 4 Accenture plc For: May 15 Filed by: Framil Leonardo
-
Form 4 Accenture plc For: May 15 Filed by: McClure Kathleen R
-
Form 4 Accenture plc For: May 15 Filed by: RENDUCHINTALA VENKATA S M
-
Form 4 Accenture plc For: May 15 Filed by: TRAVIS TRACEY THOMAS
-
Form 4 Accenture plc For: May 15 Filed by: MOONEY BETH E
-
Form 13F-HR First Citizens Asset For: Mar 31
-
Form 4 Accenture plc For: May 15 Filed by: Ardila Jaime
-
Form 4 Accenture plc For: May 15 Filed by: Unruch Joel
-
Form 4 Accenture plc For: May 15 Filed by: PELISSON Gilles
-
Form 8-K Sterling Bancorp, Inc. For: May 16
-
Form 424B2 MORGAN STANLEY
-
Form DEFA14A GENESCO INC
-
Form RW Infinera Corp
-
Form S-8 US Foods Holding Corp.
-
Form 6-K British American Tobacco For: May 17
-
Form 8-K VERINT SYSTEMS INC For: May 17
-
Form 4 INTEVAC INC For: May 16 Filed by: DURY DAVID S
-
Form 4 Mastercard Inc For: May 16 Filed by: Mastercard Foundation
-
Form 424B5 Phio Pharmaceuticals
-
Form 25-NSE AbbVie Inc. Filed by: NEW YORK STOCK EXCHANGE LLC
-
Form 1-U Masterworks Vault 4, For: May 17
-
Form SC 13D/A Arbutus Biopharma Corp Filed by: Whitefort Capital Management, LP
-
Form 25-NSE KELLANOVA Filed by: NEW YORK STOCK EXCHANGE LLC
-
Form 424B2 MORGAN STANLEY
-
Form 1-U Masterworks Vault 3, For: May 17